You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

genes BRCA2

Showing 1 - 25 of 8,902
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

Not yet recruiting
  • BRCA Mutation
  • +2 more
  • Germinal BRCA
  • (no location specified)
Mar 3, 2023

Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

Not yet recruiting
  • Metastatic Solid Tumor
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 12, 2023

HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

Completed
  • Epithelial Ovarian Cancer
  • +6 more
  • Evaluation of homologous recombination deficiency score
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Genes Contributing to Hereditary Ovarian Cancer in Women and

Completed
  • Ovarian Cancer
    • Seattle, Washington
      University of Washington
    Feb 2, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

    Not yet recruiting
    • Recurrent Metastatic Melanoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Jul 29, 2022

    Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)

    Completed
    • Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
    • Stockholm, Sweden
      Department of Woman and Child Health Karolinska University Hospi
    Jan 15, 2022

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer Trial in Napoli (Olaparib tablets)

    Recruiting
    • BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
    • Olaparib tablets
    • Napoli, Italy
      Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
    Mar 3, 2021

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Metastatic or Unresectable Melanoma Trial in Cleveland (Nivolumab, Talazoparib)

      Recruiting
      • Metastatic or Unresectable Melanoma
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
      Mar 22, 2022

      Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

      Not yet recruiting
      • Metastatic Malignant Solid Neoplasm
      • Unresectable Malignant Solid Neoplasm
      • Biopsy
      • +2 more
      • (no location specified)
      Jan 14, 2023

      Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • blood sample for BRCA2 mutation detection
      • (no location specified)
      Jun 1, 2023

      Endocrine Disruptors and Life STILe in Breast Cancer Development

      Recruiting
      • Breast Cancer
      • +5 more
        • Roma, Italy
          Alessandra Fabi
        Feb 25, 2023

        Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

        Not yet recruiting
        • Breast Cancer
        • Questionnaires
        • Communication of the results of the BRCA1/2 ultra rapid test
        • (no location specified)
        Oct 26, 2023

        BRCA and DNA Damage Repair Genes in Blood Samples of Chinese

        Recruiting
        • Pancreatic Cancer
        • Observation
        • Shanghai, Shanghai, China
          RenJiH
        Nov 17, 2021

        Searching for Novel Germline Mutations in Lobular Breast Cancer

        Recruiting
        • Lobular Breast Carcinoma
        • +3 more
        • Illumina panel
        • Milan, Italy
          European Institute of Oncology
        Sep 12, 2022

        Molecular Profiling in Prostate Cancer

        Recruiting
        • Prostate Cancer Metastatic
        • +4 more
        • Tumor molecular profiling
        • Athens, Greece
          Hellenic Cooperative Oncology Group
        Mar 15, 2022

        Identification of a Genetic Predisposition to ProstAte Cancer

        Active, not recruiting
        • Prostate Cancer in BRCA1 and BRCA2 Carriers
        • PSA test
        • Prostate Biopsy
        • Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

        Not yet recruiting
        • Pancreatic Acinar Cell Carcinoma
        • +6 more
        • Nab paclitaxel
        • +5 more
        • (no location specified)
        Oct 30, 2023

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

        Active, not recruiting
        Has Results
        • BRCA1 Gene Mutation
        • +5 more
        • Durvalumab
        • +3 more
        • Buffalo, New York
        • +1 more
        Jan 20, 2023

        Advanced Breast Cancer Trial in Spain (Olaparib)

        Completed
        • Advanced Breast Cancer
        • Badalona, Barcelona, Spain
        • +15 more
        Jan 12, 2023

        Breast Cancer Trial in New York (core needle biopsy, blood draw)

        Recruiting
        • Breast Cancer
        • core needle biopsy
        • blood draw
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Nov 9, 2023

        Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

        Not yet recruiting
        • Prostate Adenocarcinoma
        • +2 more
        • Biospecimen Collection
        • +6 more
        • (no location specified)
        Mar 28, 2023